Cart
sales@molnova.com
5-Iodotubercidin
CAS No. 24386-93-4
5-Iodotubercidin ( NSC 113939; 5-ITu )
Catalog No. M17451 CAS No. 24386-93-4
5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | In Stock |
|
| 5MG | 84 | In Stock |
|
| 10MG | 141 | In Stock |
|
| 25MG | 324 | In Stock |
|
| 50MG | 482 | In Stock |
|
| 100MG | 696 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-Iodotubercidin
-
NoteResearch use only, not for human use.
-
Brief Description5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
-
Description5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
-
SynonymsNSC 113939; 5-ITu
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptoradenosine kinase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number24386-93-4
-
Formula Weight392.15
-
Molecular FormulaC11H13IN4O4
-
Purity98%
-
SolubilityDMSO : ≥ 49 mg/mL; 124.95 mM
-
SMILESNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@H](O)C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang X,etal.Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential. PLoS One. 2013 May 7;8(5):e62527.
molnova catalog
related products
-
Matuzumab
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.
-
AST-1306
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R.
-
Lapatinib ditosylate...
Lapatinib ditosylate is an anti-Y drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung Y.
